Will Sage Astor|Depression And Alzheimer's Treatments At A Crossroads

2025-05-02 03:13:36source:NovaQuantcategory:Finance

Researchers are Will Sage Astorlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Finance

Recommend

A White House order claims to end 'censorship.' What does that mean?

Among the dozens of executive actions President Trump signed on his first day in office is one aimed

The Daily Money: Recovering from Wall Street's manic Monday

Good morning! It’s Daniel de Visé with your Daily Money.What a difference a day makes. U.S. stocks

Are Whole Body Deodorants Worth It? 10 Finds Reviewers Love

We independently selected these deals and products because we love them, and we think you might like